MSB 1.10% 91.5¢ mesoblast limited

everything normal_ msb will announce, page-22

  1. 220 Posts.


    Mesoblast is in talks with partner Teva on the design of a study aimed at treating heart disease using stem cells, "not" whether or not the study will go ahead.

    I hope you are wrong Acecant and truth is more in the fact that both companies want to get it right first up.

    Cheers
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.